In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli-Reference-Cited by-同舟云学术

In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli

Published:1984-02 Issue:2 Volume:25 Page:283-285
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Buesing M A,Jorgensen J H

Abstract

The in vitro synergistic activity of aztreonam in combination with piperacillin, moxalactam, cefotaxime, cefoperazone, and amikacin was examined against multiply resistant isolates of the family Enterobacteriaceae and Pseudomonas aeruginosa. Aztreonam in combination with amikacin demonstrated synergy against 71% of the isolates, whereas combinations of aztreonam plus a second beta-lactam demonstrated synergy against 42% of the isolates.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.25.2.283

Reference10 articles.

1. Antimicrobial synergism in the therapy of gram-negative rod bacteremia;Anderson E. T.;Chemotherapy,1978

2. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method;Hallander H.;Antimicrob. Agents Chemother.,1982

3. Significance of antimicrobial synergism for the outcome of gram-negative sepsis;Klastersky J.;Am. J. Med. Sci.,1977

4. Comparative in vitro synergistic activity of new betalactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens;Kurtz T. O.;Antimicrob. Agents Chemother.,1981

5. Livermore D. M. and J. D. Williams. 1981. In vitro activity of the monobactam SQ26 776 against gram-negative bacteria and its stability to their f-lactamases. J. Antimicrob. Chemother. 8(Suppl. E):29-37.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfer learning predicts species-specific drug interactions in emerging pathogens;2024-06-06

2. Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy;Drugs in Context;2022-01-20

3. High potency of sequential therapy with only β-lactam antibiotics;eLife;2021-07-28

4. High potency of sequential therapy with only β-lactam antibiotics;2021-07-22

5. Antimicrobials as Single and Combination Therapy for Colistin-Resistant Pseudomonas aeruginosa at a University Hospital in Thailand;Antibiotics;2020-08-03